Arrowhead Pharmaceuticals, Inc.

ARWRNASDAQHealthcare● Active

$73.86

+$0.77(+1.05%)

Market Cap$10.4B

P/E Ratio—

52W High$82.26

52W Low$14.3

Avg Volume2.0M

Open$73.20

Beta1.27

Net Income Financials Revenue

Arrowhead Pharmaceuticals, Inc. (ARWR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ARWR · net income · updated Jun 9, 2026

Core profitability metrics

ARWR · net income · margin · TTM · CAGR

Net income was −$1.6M for FY2025 (fiscal year ending 2025-09-30), up 99.7% year-over-year. Net profit margin was -0.2%. Based on available data, Arrowhead Pharmaceuticals, Inc. has been profitable since at least 2019.

FY2025 Net Income−$1.6M▲ +99.7% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin-0.2%−$1.6M ÷ $829.4M

YoY Change+99.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · ARWR net income history · ARWR profit margin

Annual net income data

ARWR · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$1.6M▲ +99.7%-0.2%$829.4M

FY2024Loss−$599.5M▼ 192.0%-16882.4%$3.6M

FY2023Loss−$205.3M▼ 16.6%-85.3%$240.7M

FY2022Loss−$176.1M▼ 25.0%-72.4%$243.2M

FY2021Loss−$140.8M▼ 66.6%-101.8%$138.3M

Net income vs peers (Healthcare)

ARWR vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Arrowhead Pharmaceuticals, Inc. (ARWR) reported net income of −$1.6M for FY2025 (fiscal year ending 2025-09-30), up 99.7% year-over-year. The net profit margin was -0.2% — meaning the company kept $-0.00 of every dollar of revenue as profit.

Based on available data, Arrowhead Pharmaceuticals, Inc. has been profitable since at least 2019. Net income reached a peak of $68.0M in FY2019. Data available for 15 fiscal years.

Arrowhead Pharmaceuticals, Inc.'s net profit margin was -0.2% for FY2025, based on the latest annual results.

Investors sometimes search for "Arrowhead Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from ARWR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ARWR net income · 4 questions

Arrowhead Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $1.6M for FY2025.

is ARWR profitabledoes ARWR make a profitARWR profitabilityARWR profitable company

▸ Source: FMP /income-statement · GAAP · Arrowhead Pharmaceuticals, Inc. · Arrowhead Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026